Tickernomics

10y

Historical Returns*:

SPY

27.80%

-18.18%

ASRT

SPY

32.66%

-53.61%

ASRT

SPY

108.59%

-83.81%

ASRT

SPY

302.52%

-98.57%

ASRT

*Assumes dividends reinvested

Market Stats:

Market Capitalization($MM)

Enterprise Value($MM)

Daily Volume(MM)

85.82

74.92

0.48

Valuation Metrics:

Price/Earnings Ratio

Price/Sales Ratio

Price/Book Value

FCF Yield(%)

Dividend Yield(%)

EV/EBITDA

-1.25

0.68

0.66

17.08

0.00

-51.92

Profitability Stats:

Operating Margin %(ttm)

Gross Profit %(ttm)

EBITDA Margin %(ttm)

-10.44

74.15

-1.18

Shareholder Value Creation:

Cost of Capital %(est)

ROIC %(ttm)

ROCE %(ttm)

Beta

7.0432

30.35

-5.49

0.74

Other Earnings and Cash Flow Stats:

Assertio Holdings Inc. ( ASRT ) Net Income TTM ($MM) is -68.49

Assertio Holdings Inc. ( ASRT ) Operating Income TTM ($MM) is -17.13

Assertio Holdings Inc. ( ASRT ) Owners' Earnings Annual ($MM) is 48.39

Assertio Holdings Inc. ( ASRT ) Current Price to Owners' Earnings ratio is 1.86

Assertio Holdings Inc. ( ASRT ) EBITDA TTM ($MM) is 0.28

Assertio Holdings Inc. ( ASRT ) EBITDA Margin is -1.18%

Capital Allocation:

Assertio Holdings Inc. ( ASRT ) has paid 0.00 dividends per share and bought back -13.639 million shares in the past 12 months

Assertio Holdings Inc. ( ASRT ) has increased its debt by 37.844 million USD in the last 12 months

Capital Structure:

Assertio Holdings Inc. ( ASRT ) Interest-bearing Debt ($MM) as of last quarter is 77

Assertio Holdings Inc. ( ASRT ) Annual Working Capital Investments ($MM) are 6

Assertio Holdings Inc. ( ASRT ) Book Value ($MM) as of last quarter is 130

Assertio Holdings Inc. ( ASRT ) Debt/Capital as of last quarter is 59%

Other Balance Sheet Stats:

Assertio Holdings Inc. ( ASRT ) has 37 million in cash on hand as of last quarter

Assertio Holdings Inc. ( ASRT ) has 90 million of liabilities due within 12 months, and long term debt 38 as of last quarter

Assertio Holdings Inc. ( ASRT ) has 95 common shares outstanding as of last quarter

Assertio Holdings Inc. ( ASRT ) has 0 million USD of preferred stock value

Academic Scores:

Assertio Holdings Inc. ( ASRT ) Altman Z-Score is -2.34 as of last quarter

Assertio Holdings Inc. ( ASRT ) Piotroski Score is 6.00 as of last quarter

Corporate Governance:

Assertio Holdings Inc. ( ASRT ) largest shareholder is owning shares at 0.00 ($MM) value

Mason Heather L(an insider) Bought 75000 shares of Assertio Holdings Inc. ( ASRT ) for the amount of $60000.00 on 2024-11-18

2.47% of Assertio Holdings Inc. ( ASRT ) is held by insiders, and 38.47% is held by institutions

Assertio Holdings Inc. ( ASRT ) went public on 1997-11-05

About Assertio Holdings Inc. ( ASRT ) :

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a preion medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.